Skip to main content
. 2014 Mar;52(3):814–822. doi: 10.1128/JCM.02488-13

TABLE 3.

Comparison of the results obtained in commercial EIAs and EIAs using recombinant antigens with the results obtained in IgM and IgG IFAs and hemagglutination inhibition test for inconclusive samples

Patient no. Result for IgM EIA (OD)
IgM IFA result Result for IgG EIA (OD)
IgG IFA result HI titer
Commercial test SFV-prME test bac-prME test IgG commercial test IgG SFV-prME test
1a 0.062 0.541a 0.667a +a 0.109 0.121 <20
2a 0.060 1.084a 1.244a +a 0.129 0.116 <20
2b 0.074a 1.696 0.998 + 0.741 0.389 + 20
2c 0.242a 0.812 0.468 + 0.196 0.180 20
2db 0.123 0.270 0.744 + 0.287 0.074 80
1b 0.052 0.107 0.103 0.577a 0.110 <20
a

Likely false-positive (1a, 2a, and 1b) and false-negative (2b and 2c) results.

b

Sample for patient no. 2d was inconclusive.